Matthias Aizenberg

Rentschler Biopharma has recently unveiled an innovative lentiviral vector (LVV) manufacturing toolbox at its advanced therapies site in Stevenage, United Kingdom, significantly enhancing its service offerings in the gene therapy sector. This strategic expansion complements their established

BioMarin Pharmaceutical, a renowned biotech firm known for its pioneering treatments for rare diseases, has recently embarked on a strategic overhaul aimed at revitalizing its growth trajectory. Faced with a period of stagnation marked by significant layoffs and halted projects, the company’s new r

In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,

Chronic skin diseases like plaque psoriasis have long posed significant challenges for patients and medical professionals alike, with existing treatments often falling short in efficacy and patient compliance. However, the emergence of Oruka Therapeutics, Inc. is positioned to revolutionize the

Theravance Biopharma Inc. (NASDAQ: TBPH) has recently garnered significant attention due to a series of notable insider transactions, varied analyst ratings, and fluctuating stock performance. These events offer deep insights into the current state and future trajectory of the company, presenting a

The advancement in biopharmaceutical research holds promise for patients with rare conditions such as relapsed/refractory AL amyloidosis. Immix Biopharma, Inc. (IMMIX), aims to tackle this debilitating disease through its innovative CAR-T cell therapy, NXC-201. As of August 28, 2024, the company

AstraZeneca has set the wheels in motion to significantly expand its biomanufacturing capacities with a $135 million investment in the Sweden Biomanufacturing Center in Södertälje. This venture marks the company's largest single investment in the facility since its inception in 2021, i

Genentech, a prominent subsidiary of Roche, is undergoing significant layoffs and restructuring efforts, which are slated to impact various roles at its South San Francisco operations. This development follows a recent announcement that 93 employees will be laid off starting in early October. The

Understanding the critical skills required in drug product formulation is pivotal for professionals in the pharmaceutical industry. This comprehensive domain encompasses various stages in the drug development process, demanding a multidisciplinary skill set that includes a robust foundation in

The U.S. Food and Drug Administration (FDA) has recently given its stamp of approval to updated COVID-19 vaccines from Pfizer and Moderna, marking a significant advancement in the ongoing efforts to combat the virus. These newly formulated vaccines are specifically designed to target the currently